Latest Balance Sheet News

Page 304 of 308
Invictus Energy has completed a key legal review and secured $12 million in funding, setting the stage for expanded drilling and development in Zimbabwe's Cabora Bassa Basin.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Paradigm Biopharmaceuticals has secured a $6.3 million R&D Tax Incentive refund, lifting its cash reserves to $31 million and reinforcing its push into Phase 3 osteoarthritis clinical trials.
Victor Sage
Victor Sage
24 Jan 2025
Top Shelf International Holdings Ltd has agreed to sell its Campbellfield production assets to Idyll Wine Co for $8 million, aiming to streamline operations and reduce debt. The deal paves the way for a new co-packing partnership post-sale.
Victor Sage
Victor Sage
24 Jan 2025
BSA Limited reported a robust Q2 FY2025 with revenue up 10.7% and EBITDA surging 31.5%, underpinned by a key contract extension with nbn. The company has upgraded its full-year EBITDA guidance, signaling confidence in sustained profitability.
Sophie Babbage
Sophie Babbage
24 Jan 2025
Great Western Exploration has completed initial drilling at its Oval copper-gold target and is advancing approvals for further drilling at its Sumo niobium and Juggernaut VHMS copper-gold targets, while divesting its non-core Yandal West gold project.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Great Western Exploration Limited reported a $191,000 net cash outflow from operations in the December quarter but bolstered its cash reserves to $4.74 million through a $3.6 million capital raise, maintaining a solid financial footing for ongoing exploration.
Maxwell Dee
Maxwell Dee
24 Jan 2025
KMD Brands reports improving sales in direct-to-consumer channels for FY25’s first five months, offset by ongoing wholesale challenges and a forecasted dip in EBITDA.
Logan Eniac
Logan Eniac
24 Jan 2025
Peregrine Gold secures a significant $1 million commitment from its largest shareholder, Yandal Investments, strengthening its entitlement offer ahead of the project sale to Capricorn Metals.
Maxwell Dee
Maxwell Dee
23 Jan 2025
Nyrada Inc. reports promising preclinical results for its lead drug NYR-BI03, showing an 86% cardioprotective effect, alongside a strong financial position bolstered by a AU$3.29 million capital raise. The company has submitted its Phase Ia clinical trial package, setting the stage for human testing.
Ada Torres
Ada Torres
23 Jan 2025
Vonex Limited reports solid operational improvements and customer satisfaction in Q2 FY25, while endorsing Maxo Telecommunications’ takeover offer and planning a $13 million capital raise to manage debt.
Sophie Babbage
Sophie Babbage
23 Jan 2025
Investigator Resources Limited has postponed the Definitive Feasibility Study (DFS) for its Paris Silver Project to mid-2025, citing rising costs and the need for further optimisation. Meanwhile, exploration drilling continues and asset sales bolster the company’s cash position to $2.7 million.
Maxwell Dee
Maxwell Dee
23 Jan 2025
Santos delivered a robust Q4 2024 with over US$1.4 billion in sales revenue and strong free cash flow, while progressing key LNG projects and expanding its decarbonisation initiatives.
Maxwell Dee
Maxwell Dee
23 Jan 2025